Figure 1
Cumulative incidence of sclerosis after initial systemic treatment for chronic GVHD. Seventy (7%) of the 977 patients presented with sclerotic features at the time of initial systemic treatment for chronic GVHD.
Cumulative incidence of sclerosis after initial systemic treatment for chronic GVHD. Seventy (7%) of the 977 patients presented with sclerotic features at the time of initial systemic treatment for chronic GVHD.
